LTKfarma established in France
LTKfarma, a French biopharmaceutical firm focused on cell therapy products derived from modified T-cells to treat leukemia and autoimmune diseases, has announced its creation and selected members to its advisory board.
Appointees drawn from industry include Alain Clergeot, president of Chugai Pharma France, and Tamara Joseph, general counsel and corporate secretary of Mayne Pharma and former vice president of Biogen Idec. Jean-Francois Labbe, a former chief operating officer of ProStrakan, joins from Hoechst Marion Roussel.
Laurent de Narbonne, general manager of Octapharma France, Belgium and Luxemburg, who is also chairman of the firm, joins the advisory board, together with Leo van Wersch, former president of Procter & Gamble Pharmaceuticals France.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze